Intraocular Melanoma in Adults | NYU Langone Health
Perlmutter Cancer Center specialists offer expert care for people with intraocular melanoma, or choroidal melanoma, a cancer that begins in the eye.
Intrathecal Therapy for Acute Myeloid Leukemia | NYU Langone Health
NYU Langone doctors may recommend intrathecal therapy to destroy leukemia cells for people with acute myeloid leukemia.
Intrathecal Therapy for Leukemia in Children | NYU Langone Health
Doctors at Hassenfeld Children’s Hospital recommend intrathecal therapy to protect the central nervous system during chemotherapy for acute childhood leukemia.
Intrathecal Therapy for Non-Hodgkin Lymphoma in Children | NYU Langone Health
Doctors at Hassenfeld Children’s Hospital at NYU Langone use intrathecal therapy to protect the central nervous system during chemotherapy.
Intravenous Treatment for Sepsis in Children | NYU Langone Health
At Hassenfeld Children’s Hospital at NYU Langone, children with sepsis receive IV treatments to combat infection and symptoms.
Intravesical Therapy for Bladder Cancer | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center may use intravesical immunotherapy or intravesical chemotherapy to treat bladder cancer.
INTREPId (INTermediate Risk Erection PreservatIon Trial): A Randomized Trial of Radiation Therapy and Darolutamide for Prostate Cancer
This is a randomized non-inferiority trial of 6-months of gonadotropin releasing hormone (GnRH) agonist and bicalutamide plus radiation therapy (RT) versus 6-months of Darolutamide plus RT for intermediate risk prostate cancer. Participants will be stratified by Decipher classification (low/intermediate vs high risk), RT modality (EBRT vs Brachytherapy/SBRT/combination RT), and age (>65 vs
Investigating auditory processing in the users of auditory brainstem and cochlear implants
This is a basic investigational research study conducted with hearing impaired adults and children who use cochlear implant or auditory brainstem implant (ABI) devices. The study will evaluate different aspects of hearing and auditory processing in the users of implantable auditory devices.
Investigating Dynamic Causes of Dorsal Wrist Pain
This is a prospective cohort study to evaluate for causes of dorsal wrist pain using a Wrist Glove MRI Coil to allow for dynamic imaging, with live motion MRI to assess for normal carpal anatomy and position through normal wrist range of motion. The study will include 50 individuals 18+ years of age with dorsal wrist pain and 15 healthy volunteers 18+ years of age without wrist pain who will individually be evaluated over a one month period with a total study duration of 24 month. MRIs will be collected on all patients and evaluated for primary and secondary objectives.
Investigating the Temperature Dependence of Age-related Tau Pathology Relevant to Early Alzheimer's Disease
This is a cross-sectional study in 100 older adults (n = 100, 50 female, 60–80 years) who are cognitively normal (n = 70) or have mild cognitive impairment (n = 30). The purpose is to test whether features of body temperature (Tb), measured with ingestible telemetry, are associated with tau pathology, measured with [18-F]-MK-6240 tau PET-MR and plasma P-tau. Participant involvement includes 6 study visits over a period of 4 months. The duration of the project is 5 years. Briefly, subjects who express interest and are eligible for screening based on a pre-screening call will undergo in-person medical screening and complete several intake questionnaires at Visit 1, followed by a blood draw at CTSI, a clinical interview and neuropsychological testing at Visit 2. A 7-day at-home sleep assessment and actigraphy data, after Visit 2, will help us determine sleep-wake cycles and screen for Obstructive Sleep Apnea which is exclusionary for our study, if severe. At Visits 3 & 4, subjects will undergo body temperature measurements with ingestible telemetric thermometry over 48 hours, commencing on Night 1 of a 48 hour visit to the MSCIC sleep lab. Sleep EEG characteristics will be assessed with polysomnography on Nights 1 and 2 of this 48 hour period. During the day between these nights, subjects will be free to return home. After sleep study data is analyzed, the Eligibility Checklist can be completed. At Visit 5 which will take place at least 7 days after the sleep study completion, subjects will undergo a Tau PET/MR scan at the Center for Biomedical Imaging. At Visit 6, at least 7 days after the sleep study (but not on the same day as the Tau PET/MR) subjects will undergo an amyloid PET/MR scan. The purpose of the PET/MR scans is to control for tau and amyloid burden in the central nervous system.This cross-sectional study will lay the ground work for future prospective studies to determine whether Tb based interventions can prevent the progression of NFT pathology toward reducing Alzheimer’s Disease burden.